Institute for Diabetes and Endocrinology, La lolla, California 92(1.?7 Treatment of Swiss 3T3 fibroblasts with basic fibroblast growth factor (bFGF) lead to a rapid reduction in epidermal growth factor (EGF) binding and a slower inhibition of EGF receptor autophosphorylation. The reduction in bindi
Regulation of epidermal growth factor (EGF) receptor activity during the modulation of protein synthesis
✍ Scribed by Graham Carpenter
- Publisher
- John Wiley and Sons
- Year
- 1979
- Tongue
- English
- Weight
- 425 KB
- Volume
- 99
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The capacity of cultured human fibroblasts to bind ^125^I‐labeled epidermal growth factor (EGF) was measured during protein synthesis inhibition and reinitiation. Protein synthesis was inhibited by incubation of human fibroblasts in histidine‐free medium supplemented with L‐histidinol to produce a stringent amino acid starvation. Under these conditions ^125^I‐EGF binding activity decreased with a half‐life of 14.5 hours. Protein synthesis could be rapidly reinitiated by the addition of L‐histidine to human fibroblasts which had been preincubated in histidinol containing media for 36 to 48 hours. ^125^I‐EGF binding activity rapidly increased upon the reinitiation of protein synthesis. In the presence of serum 100% of the original binding capacity was recovered ten hours after the renitiation of protein synthesis, while 70% of the binding capacity was recovered in 12 hours in serum‐free media. The recovery of ^125^I‐EGF binding activity after the reinitiation of protein synthesis, was not blocked by the presence of Actinomycin D, indicating that the messenger RNA for the EGF receptor may accumulate during the period of histidinol‐mediated inhibition of protein synthesis. The time course of recovery of ^125^I‐EGF binding activity after the reinitiation of protein synthesis is very similar to that observed during the recovery of receptor activity following “down regulation” of EGF receptor activity. Recovery from down regulation, however, was markedly sensitive to Actinomycin D.
📜 SIMILAR VOLUMES
The receptor for epidermal growth factor (EGF) is a glycosylated transmembrane phosphoprotein that exhibits EGF-stimulable protein tyrosine kinase activity. On EGF stimulation, the receptor undergoes a self-phosphorylation reaction at tyrosine residues located primarily in the extreme carboxyl-termi
Normal rat kidney (NRK) fibroblasts are immortalized cells that are strictly dependent on externally added growth factors for proliferation. When cultured in the presence of epidermal growth factor (EGF) as the only growth stimulating hormone, these cells have a normal phenotype and undergo density-
The functional role of epidermal growth factor (EGF) in epithelium-derived human colonic carcinoma cells was investigated by transfection with plasmid pUCDS3, which contained synthetic human EGF encoding sequences, into two human colonic carcinoma cell types with dissimilar phenotypic properties: th
Epidermal growth factor (EGF) causes gender-and development-specific changes in fetal lung surfactant synthesis. We hypothesized that the effects of EGF on development of surfactant synthesis are related to effects on EGF receptor (EGF-R) expression. We prepared sex-specific fetal rabbit lung organ
Human plasma protein S is a nonenzymatic cofactor for activated protein C (APC) in the inactivation of coagulation factors Va and VIIIa, and helps to provide an essential negative feedback on blood coagulation. Previous indirect evidence suggested that the thrombin-sensitive region (TSR: residues 47